| Single sample scoring of molecular phenotypes M Foroutan, DD Bhuva, R Lyu, K Horan, J Cursons, MJ Davis BMC bioinformatics 19, 1-10, 2018 | 316 | 2018 |
| A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients J Cursons, F Souza-Fonseca-Guimaraes, M Foroutan, A Anderson, ... Cancer immunology research 7 (7), 1162-1174, 2019 | 212 | 2019 |
| Combinatorial targeting by microRNAs co-ordinates post-transcriptional control of EMT J Cursons, KA Pillman, KG Scheer, PA Gregory, M Foroutan, ... Cell systems 7 (1), 77-91. e7, 2018 | 105 | 2018 |
| A transcriptional program for detecting TGFβ-induced EMT in cancer M Foroutan, J Cursons, S Hediyeh-Zadeh, EW Thompson, MJ Davis Molecular Cancer Research 15 (5), 619-631, 2017 | 72 | 2017 |
| Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines J Cursons, KJ Leuchowius, M Waltham, E Tomaskovic-Crook, M Foroutan, ... Cell Communication and Signaling 13, 1-21, 2015 | 52 | 2015 |
| Removing unwanted variation from large-scale RNA sequencing data with PRPS R Molania, M Foroutan, JA Gagnon-Bartsch, LC Gandolfo, A Jain, A Sinha, ... Nature Biotechnology 41 (1), 82-95, 2023 | 22 | 2023 |
| The ratio of exhausted to resident infiltrating lymphocytes is prognostic for colorectal cancer patient outcome M Foroutan, R Molania, A Pfefferle, C Behrenbruch, S Scheer, A Kallies, ... Cancer Immunology Research 9 (10), 1125-1140, 2021 | 21 | 2021 |
| Using singscore to predict mutation status in acute myeloid leukemia from transcriptomic signatures DD Bhuva, M Foroutan, Y Xie, R Lyu, J Cursons, MJ Davis F1000Research 8, 2019 | 18 | 2019 |
| Tgfβ and cis inhibition overcomes NK-cell suppression to restore antitumor immunity F Souza-Fonseca-Guimaraes, GR Rossi, LF Dagley, M Foroutan, ... Cancer Immunology Research 10 (9), 1047-1054, 2022 | 14 | 2022 |
| CSK-homologous kinase (CHK/MATK) is a potential colorectal cancer tumour suppressor gene epigenetically silenced by promoter methylation AC Chüeh, G Advani, M Foroutan, J Smith, N Ng, H Nandurkar, DS Lio, ... Oncogene 40 (17), 3015-3029, 2021 | 13 | 2021 |
| Targeting WEE1/AKT Restores p53-dependent natural killer–cell activation to induce immune checkpoint blockade responses in “cold” melanoma SS Dinavahi, YC Chen, K Punnath, A Berg, M Herlyn, M Foroutan, ... Cancer immunology research 10 (6), 757-769, 2022 | 12 | 2022 |
| Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer C Waryah, J Cursons, M Foroutan, C Pflueger, E Wang, R Molania, ... Advanced Science 10 (22), 2301802, 2023 | 10 | 2023 |
| Networking and Bayesian analyses of genetic affinity in cotton germplasm Z Noormohammadi, M Sheidai, M Foroutan, O Alishah The Nucleus 58, 33-45, 2015 | 7 | 2015 |
| Structure analysis of genetic diversity in tetraploid and diploid cotton genotypes Z Noormohammadi, E Taghavi, M Foroutan, M Sheidai, O Alishah International Journal of Plant, Animal and Environmental Sciences 3 (1), 79-90, 2013 | 7 | 2013 |
| Targeting of TP53-independent cell cycle checkpoints overcomes FOLFOX resistance in Metastatic Colorectal Cancer C Behrenbruch, M Foroutan, P Lind, J Smith, M Grandin, B Cooper, ... BioRxiv, 2021.02. 04.429849, 2021 | 6 | 2021 |
| A natural killer cell gene signature predicts melanoma patient survival J Cursons, F Souza-Fonseca-Guimaraes, A Anderson, M Foroutan, ... bioRxiv, 375253, 2018 | 5 | 2018 |
| Post-transcriptional control of EMT is coordinated through combinatorial targeting by multiple microRNAs J Cursons, KA Pillman, K Scheer, PA Gregory, M Foroutan, SH Zadeh, ... bioRxiv, 138024, 2017 | 5 | 2017 |
| Computational screening of anti-cancer drugs identifies a new BRCA independent gene expression signature to predict breast cancer sensitivity to cisplatin J Berthelet, M Foroutan, DD Bhuva, HJ Whitfield, F El-Saafin, J Cursons, ... Cancers 14 (10), 2404, 2022 | 3 | 2022 |
| Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma A Sgro, J Cursons, C Waryah, EA Woodward, M Foroutan, R Lyu, ... Clinical Epigenetics 15 (1), 73, 2023 | 2 | 2023 |
| A new highly-specific Natural Killer cell-specific gene signature predicting recurrence in colorectal cancer patients C Shembrey, C Behrenbruch, BPT Loveday, AG Heriot, M Foroutan, ... bioRxiv, 2022.04. 29.489868, 2022 | 2 | 2022 |
